AP
Arpit Pokharna
About Arpit Pokharna
Data last updated:
Arpit Pokharna is a Director at Njbio India Pharmaceutical Private Limited (since 2023). The company operates in Travel and Hospitality. Njbio India Pharmaceutical Private Limited reported revenue of ₹15.20 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2023 | 2019 | ₹15.20 Cr (FY 2025) | Active |
Board colleagues of Arpit Pokharna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hetvi Alpesh Sheth | Njbio India Pharmaceutical Private Limited | Company Secretary | |
| Nareshkumar Fulchand Jain | 02418733 | Njbio India Pharmaceutical Private Limited | Director |
| Rahul Suresh Bagul | 10869764 | Njbio India Pharmaceutical Private Limited | Whole-Time Director |
| Swati Mathur | Njbio India Pharmaceutical Private Limited | Cfo | |
| Tanveer Fatima | Njbio India Pharmaceutical Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arpit Pokharna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arpit Pokharna
Arpit Pokharna currently holds 1 directorship: Njbio India Pharmaceutical Private Limited (Director, since 01 Sep 2023, revenue ₹15.20 Cr (FY 2025)).
Arpit Pokharna was first appointed on 01 Sep 2023 as Director at Njbio India Pharmaceutical Private Limited.
The current boards of Arpit Pokharna's companies include Hetvi Alpesh Sheth (Njbio India Pharmaceutical Private Limited), Nareshkumar Fulchand Jain (Njbio India Pharmaceutical Private Limited), Rahul Suresh Bagul (Njbio India Pharmaceutical Private Limited), Swati Mathur (Njbio India Pharmaceutical Private Limited), Tanveer Fatima (Njbio India Pharmaceutical Private Limited).